| Product NDC: | 0169-6339 |
| Proprietary Name: | NovoLog |
| Non Proprietary Name: | insulin aspart |
| Active Ingredient(s): | 100 [iU]/mL & nbsp; insulin aspart |
| Administration Route(s): | INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0169-6339 |
| Labeler Name: | Novo Nordisk |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020986 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20030122 |
| Package NDC: | 0169-6339-97 |
| Package Description: | 1 SYRINGE, PLASTIC in 1 CARTON (0169-6339-97) > 3 mL in 1 SYRINGE, PLASTIC |
| NDC Code | 0169-6339-97 |
| Proprietary Name | NovoLog |
| Package Description | 1 SYRINGE, PLASTIC in 1 CARTON (0169-6339-97) > 3 mL in 1 SYRINGE, PLASTIC |
| Product NDC | 0169-6339 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | insulin aspart |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 20030122 |
| Marketing Category Name | NDA |
| Labeler Name | Novo Nordisk |
| Substance Name | INSULIN ASPART |
| Strength Number | 100 |
| Strength Unit | [iU]/mL |
| Pharmaceutical Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |